raloxifene hydrochloride has been researched along with estriol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, J | 1 |
Bacchi Modena, A; Baldini, M; Benassi, L; Dei Cas, A; Luciana Barilli, A; Manotti, C; Rinaldi, M; Sgarabotto, M | 1 |
Cegieła, U; Folwarczna, J; Kaczmarczyk-Sedlak, I; Nowińska, B; Pytlik, M; Sliwiński, L; Trzeciak, H; Trzeciak, HI | 1 |
Hayashi, T; Ina, K; Maeda, M; Nomura, H | 1 |
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS | 1 |
2 review(s) available for raloxifene hydrochloride and estriol
Article | Year |
---|---|
[Comparative analyses on osteoporosis guidelines in Japan, EU and USA].
Topics: Alendronate; Calcitonin; Clinical Trials as Topic; Drug Approval; Estriol; Etidronic Acid; Europe; Humans; Isoflavones; Japan; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; United States; Vitamin K 2 | 2002 |
Add-back therapy with GnRH analogues for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms | 2015 |
2 trial(s) available for raloxifene hydrochloride and estriol
Article | Year |
---|---|
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Topics: Aged; Body Mass Index; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors | 2007 |
The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
Topics: Adiponectin; Aged; Blood Glucose; Bone Density; Cholesterol, HDL; Cholesterol, LDL; Estriol; Estrogen Replacement Therapy; Female; Humans; Japan; Medroxyprogesterone; Nitric Oxide; Osteoporosis; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tumor Necrosis Factor-alpha | 2011 |
1 other study(ies) available for raloxifene hydrochloride and estriol
Article | Year |
---|---|
A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Calcification, Physiologic; Calcium; Cell Count; Cells, Cultured; Disease Models, Animal; Drug Combinations; Estradiol; Estriol; Female; Gene Expression; Genistein; Humans; Mice; Mice, Inbred BALB C; Organ Size; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; RNA, Messenger; Selective Estrogen Receptor Modulators; Thymus Gland; Uterus | 2009 |